The European Union’s public-private partnership for drug development research, the Innovative Medicines Initiative, is to formally collaborate with the US Critical Path Institute, in a move to share more information from pre-competitive research. ---Subscribe to MedNous to access this article--- Research & University News Regulation & Policy
